Corindus

Corindus Vascular Robotics, Inc. is the global technology leader in robotic-assisted vascular interventions. The company's CorPath® platform is the first FDA-cleared medical device that brings robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology, which enhances platform capabilities by adding significant key upgrades, improving precision, optimizing workflow, and expanding the functionality and range of procedures that can be automated. Committed to developing innovative robotic solutions to revolutionize emergency treatment methods by providing specialized and timely medical care to patients worldwide.